...
首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
【24h】

Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.

机译:芬兰和荷兰的大规模筛查计划和子宫颈癌趋势。

获取原文
获取原文并翻译 | 示例
           

摘要

With respect to cervical cancer management, Finland and the Netherlands are comparable in relevant characteristics, e.g., fertility rate, age-of-mother at first birth and a national screening programme for several years. The aim of this study is to compare trends in incidence of and mortality from cervical cancer in Finland and the Netherlands in relation to the introduction and intensity of the screening programmes. Therefore, incidence and mortality rates were calculated using the Cancer Registries of Finland and the Netherlands. Data on screening intensity were obtained from the Finnish Cancer Registry and the Dutch evaluation centre at ErasmusMC-Rotterdam. Women aged 30-60 have been screened every 5 years, in Finland since 1992 and in the Netherlands since 1996. Screening protocols for smear taking and referral to the gynaecologist are comparable. Incidence and mortality rates have declined more in Finland. In 2003, age-adjusted incidence and mortality in Finland were 4.0 and 0.9 and in the Netherlands 4.9 and 1.4 per 100,000 woman-years, respectively. Excess smear use in the Netherlands was estimated to be 24 per 1,000 women during a 5-year interval compared to 121 in Finland. The decline in mortality in Finland seems to be almost completely related to the screening programme whereas in the Netherlands it was initially considered to be a natural decline. Differences in risk factors might also play a role: the Netherlands has higher population density and higher percentages of immigrants and (female) smokers. The greater excess smear use in Finland might also have affected incidence.
机译:在宫颈癌的管理方面,芬兰和荷兰在相关特征方面具有可比性,例如,生育率,初生母亲的年龄和几年的国家筛查计划。这项研究的目的是比较芬兰和荷兰宫颈癌的发病率和死亡率与筛查计划的引入和强度的趋势。因此,使用芬兰和荷兰的癌症登记处计算发病率和死亡率。筛查强度的数据是从芬兰癌症登记处和位于鹿特丹的ErasmusMC荷兰评估中心获得的。自1992年以来在芬兰和荷兰自1996年以来,每5年对30至60岁的女性进行一次筛查。筛查涂片和转诊至妇科医生的方案相当。芬兰的发病率和死亡率下降幅度更大。 2003年,按年龄调整的发病率和死亡率在芬兰分别是4.0和0.9,在荷兰则是每100,000妇女年4.9和1.4。据估计,在5年的时间间隔内,荷兰过度使用涂片的比例为每1000名女性中有24名使用,而芬兰为121。芬兰的死亡率下降似乎几乎与筛查计划完全相关,而在荷兰,起初认为这是自然下降。危险因素的差异也可能起作用:荷兰的人口密度更高,移民和(女性)吸烟者的比例更高。芬兰更多地使用过量涂片可能也影响了发病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号